To identify other TF potentially regulating CCND2 enhancer activity in CCND2-expressing HD MM (which lack expression of MAF), we performed differential footprinting analysis in CCND2high vs CCND2low HD myeloma PC (Fig. 5g and Supplementary Fig. 6f and g). The gene discussed is CCND2; the disease is Huntington disease.